-transparent.png){kind=logo}
The authors reviewed 92 patients diagnosed as ALL. Age range was 1 to 12 years (x = 5 years), 50 males and 42 females. The patients were classified as high risk, intermediate and low risk according to the following prognostic factors: sex, age at diagnosis, visceromegaly, adenopathy, initial WBC, HB, immunoglobulins, and platelets, FAB morphological classification, and bone marrow response to initial therapy, immunological markers, CNS infiltration and mediastinal mass. The previous factors were analyzed individually and also the results obtained with each risk group according to the treatment applied.
Related Publications
E Moya, and
J L Bezanilla, and
A Navajas, and
M A Piñán, and
M J Sebastián
August 1979,
Minerva pediatrica,
E Moya, and
J L Bezanilla, and
A Navajas, and
M A Piñán, and
M J Sebastián
November 1992,
Leukemia,
E Moya, and
J L Bezanilla, and
A Navajas, and
M A Piñán, and
M J Sebastián
January 2000,
Journal of pediatric hematology/oncology,
E Moya, and
J L Bezanilla, and
A Navajas, and
M A Piñán, and
M J Sebastián
January 1992,
Pediatrie,
E Moya, and
J L Bezanilla, and
A Navajas, and
M A Piñán, and
M J Sebastián
April 2012,
Nihon rinsho. Japanese journal of clinical medicine,
E Moya, and
J L Bezanilla, and
A Navajas, and
M A Piñán, and
M J Sebastián
August 2003,
Hematology (Amsterdam, Netherlands),
E Moya, and
J L Bezanilla, and
A Navajas, and
M A Piñán, and
M J Sebastián
January 1979,
Haematology and blood transfusion,
E Moya, and
J L Bezanilla, and
A Navajas, and
M A Piñán, and
M J Sebastián
September 1997,
Annals of the New York Academy of Sciences,
E Moya, and
J L Bezanilla, and
A Navajas, and
M A Piñán, and
M J Sebastián
January 1993,
Hematologic pathology,
E Moya, and
J L Bezanilla, and
A Navajas, and
M A Piñán, and
M J Sebastián
January 1995,
Pediatric hematology and oncology,
